Skip to main content
Top
Published in: Gastric Cancer 4/2018

01-07-2018 | Original Article

Higher risk of gastric cancer among immigrants to Ontario: a population-based matched cohort study with over 2 million individuals

Authors: Rinku Sutradhar, Nnenna Asidianya, Faith Lee, Natalie Coburn, Linda Rabeneck, Lawrence Paszat

Published in: Gastric Cancer | Issue 4/2018

Login to get access

Abstract

Background

The risk of gastric carcinoma (GC) varies around the world and between females and males. We aimed to compare the risk of GC among immigrants to Ontario, Canada, to the risk of GC in its general population.

Methods

This was a retrospective population-based matched cohort study from 1991 to 2014. We identified immigrants who were first eligible for the Ontario Health Insurance Plan at age 40 years or older, and matched 5 controls by year of birth and sex. We calculated crude rates and relative rates of GC stratified by sex. We modeled GC hazard using multivariable Cox proportional hazards regression, where a time-varying coefficient was incorporated to examine changes in the association of immigrant status with GC hazard over time.

Results

Among females, 415 GC cases were identified among 209,843 immigrants and 1872 among 1,049,215 controls. Among males, 596 GC cases were identified among 191,792 immigrants and 2998 among 958,960 controls. Comparing immigrants from East Asia and Pacific with the controls, the crude relative rate of GC was 1.54 for females and 1.32 for males. The adjusted hazard ratio (HR) for GC among female immigrants was 1.29 [95% confidence interval (CI) 1.12, 1.48] within 10 years and 1.19 (1.01, 1.40) beyond 10 years; for males, the HR was 1.17 (1.04, 1.31) within 10 years and 1.00 (0.87, 1.15) beyond 10 years.

Conclusion

The risk of GC among immigrants is elevated. Although high-risk immigrant populations in Ontario have been identified, further knowledge is required before a program of GC prevention that is targeted to them can be planned.
Literature
1.
go back to reference Freedman ND, Derakhshan MH, Abnet CC, Schatzkin A, Hollenbeck AR, McColl KEL. Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women. Eur J Cancer. 2010;46:2473–8.CrossRefPubMedPubMedCentral Freedman ND, Derakhshan MH, Abnet CC, Schatzkin A, Hollenbeck AR, McColl KEL. Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women. Eur J Cancer. 2010;46:2473–8.CrossRefPubMedPubMedCentral
2.
go back to reference Camargo MC, Goto Y, Zabaleta J, Morgan DR, Correa P, Rabkin CS. Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2012;21:20–38.CrossRef Camargo MC, Goto Y, Zabaleta J, Morgan DR, Correa P, Rabkin CS. Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2012;21:20–38.CrossRef
3.
go back to reference Ang TL, Fock KM. Clinical epidemiology of gastric cancer. Singap Med J. 2014;55:621–8.CrossRef Ang TL, Fock KM. Clinical epidemiology of gastric cancer. Singap Med J. 2014;55:621–8.CrossRef
5.
go back to reference Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136:487–90.CrossRefPubMed Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136:487–90.CrossRefPubMed
7.
go back to reference Moss SF. The clinical evidence linking Helicobacter pylori to gastric cancer. Cell Mol Gastroenterol Hepatol. 2017;3:183–91.CrossRefPubMed Moss SF. The clinical evidence linking Helicobacter pylori to gastric cancer. Cell Mol Gastroenterol Hepatol. 2017;3:183–91.CrossRefPubMed
8.
go back to reference Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165:1424–33.CrossRefPubMed Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165:1424–33.CrossRefPubMed
9.
go back to reference Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008;19:689–701.CrossRefPubMed Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008;19:689–701.CrossRefPubMed
10.
go back to reference Chen I, Mathews-Greiner L, Li D, Abisoye-Ogunniyan A, Ray S, Bian Y, et al. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer. J Transl Med. 2017;15:92.CrossRefPubMedPubMedCentral Chen I, Mathews-Greiner L, Li D, Abisoye-Ogunniyan A, Ray S, Bian Y, et al. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer. J Transl Med. 2017;15:92.CrossRefPubMedPubMedCentral
11.
go back to reference Yaghoobi M, Nabb-Baltar J, Bijarchi R, Hunt RH. What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analysis. World J Gastroenterol. 2017;23:2435.CrossRefPubMedPubMedCentral Yaghoobi M, Nabb-Baltar J, Bijarchi R, Hunt RH. What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analysis. World J Gastroenterol. 2017;23:2435.CrossRefPubMedPubMedCentral
12.
go back to reference Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1–27.CrossRefPubMed Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1–27.CrossRefPubMed
16.
go back to reference Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst. 1968;40:43–68.PubMed Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst. 1968;40:43–68.PubMed
17.
go back to reference Shimizu H, Mack TM, Ross RK, Henderson BE. Cancer of the gastrointestinal tract among japanese and white immigrants in Los Angeles County 2. J Natl Cancer Inst. 1987;78:223–8. Shimizu H, Mack TM, Ross RK, Henderson BE. Cancer of the gastrointestinal tract among japanese and white immigrants in Los Angeles County 2. J Natl Cancer Inst. 1987;78:223–8.
18.
go back to reference Loffeld RJ, Van Der Putten AB. Changes in prevalence of Helicobacter pylori infection in two groups of patients undergoing endoscopy and living in the same region in the Netherlands. Scand J Gastroenterol. 2003;38:938–41.CrossRefPubMed Loffeld RJ, Van Der Putten AB. Changes in prevalence of Helicobacter pylori infection in two groups of patients undergoing endoscopy and living in the same region in the Netherlands. Scand J Gastroenterol. 2003;38:938–41.CrossRefPubMed
19.
go back to reference Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomark Prev. 2014;23:700–13.CrossRef Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomark Prev. 2014;23:700–13.CrossRef
21.
go back to reference Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection: The Maastricht V/Florence Consensus Report. Gut. 2017;66:6–30. Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection: The Maastricht V/Florence Consensus Report. Gut. 2017;66:6–30.
23.
go back to reference Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150:1113–24.CrossRefPubMed Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150:1113–24.CrossRefPubMed
24.
go back to reference Hamashima C, Ogoshi K, Okamoto M, Shabana M, Kishimoto T, Fukao A. A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLoS One. 2013;8:e79088.CrossRefPubMedPubMedCentral Hamashima C, Ogoshi K, Okamoto M, Shabana M, Kishimoto T, Fukao A. A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLoS One. 2013;8:e79088.CrossRefPubMedPubMedCentral
25.
go back to reference Sutradhar R, Gu S, Paszat L. Multistate transitional models for measuring adherence to breast cancer screening: a population-based longitudinal cohort study with over 2 million women. J Med Screen. 2017;24(2):75–82 (PMID 27440758).CrossRefPubMed Sutradhar R, Gu S, Paszat L. Multistate transitional models for measuring adherence to breast cancer screening: a population-based longitudinal cohort study with over 2 million women. J Med Screen. 2017;24(2):75–82 (PMID 27440758).CrossRefPubMed
26.
go back to reference Lofters AK, Hwang SW, Moineddin R, Glazier RH. Cervical cancer screening among urban immigrants by region of origin: a population-based cohort study. Prev Med. 2010;51:509–16.CrossRefPubMed Lofters AK, Hwang SW, Moineddin R, Glazier RH. Cervical cancer screening among urban immigrants by region of origin: a population-based cohort study. Prev Med. 2010;51:509–16.CrossRefPubMed
28.
go back to reference Lofters AK, Moineddin R, Hwang SW, Glazier RH. Predictors of low cervical cancer screening among immigrant women in Ontario, Canada. BMC Womens Health. 2011;11:20.CrossRefPubMedPubMedCentral Lofters AK, Moineddin R, Hwang SW, Glazier RH. Predictors of low cervical cancer screening among immigrant women in Ontario, Canada. BMC Womens Health. 2011;11:20.CrossRefPubMedPubMedCentral
29.
go back to reference Rosner B. Fundamentals of biostatistics. 6th ed. Belmont: Duxbury Press; 2006. Rosner B. Fundamentals of biostatistics. 6th ed. Belmont: Duxbury Press; 2006.
30.
go back to reference Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York: Springer; 2000.CrossRef Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York: Springer; 2000.CrossRef
31.
go back to reference Allison PD. Survival analysis using SAS: a practical guide. 2nd ed. Cary: SAS Institute; 1995. Allison PD. Survival analysis using SAS: a practical guide. 2nd ed. Cary: SAS Institute; 1995.
32.
go back to reference R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2009. http://www.R-project.org. Accessed 28 July 2014. R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2009. http://​www.​R-project.​org. Accessed 28 July 2014.
33.
go back to reference McDermott S, Desmeules M, Lewis R, Gold J, Payne J, Lafrance B, Vissandjée B, Kliewer E, Mao Y. Cancer incidence among Canadian immigrants, 1980–1998: results from a national cohort study. J Immigr Minor Health. 2011;13(1):15–26.CrossRefPubMed McDermott S, Desmeules M, Lewis R, Gold J, Payne J, Lafrance B, Vissandjée B, Kliewer E, Mao Y. Cancer incidence among Canadian immigrants, 1980–1998: results from a national cohort study. J Immigr Minor Health. 2011;13(1):15–26.CrossRefPubMed
34.
go back to reference Park JY, Forman D, Greenberg ER, Herrero R. Helicobacter pylori eradication in the prevention of gastric cancer: are more trials needed? Curr Oncol Rep. 2013;15:517–25.CrossRefPubMed Park JY, Forman D, Greenberg ER, Herrero R. Helicobacter pylori eradication in the prevention of gastric cancer: are more trials needed? Curr Oncol Rep. 2013;15:517–25.CrossRefPubMed
35.
go back to reference Cheng HC, Wang JD, Chen WY, Chen CW, Chang SC, Sheu BS. Helicobacter pylori test-and-treat program can be cost-effective to prevent gastric cancer in Taiwanese adults: referred to the Nationwide Reimbursement Database. Helicobacter. 2015;20:114–24. Cheng HC, Wang JD, Chen WY, Chen CW, Chang SC, Sheu BS. Helicobacter pylori test-and-treat program can be cost-effective to prevent gastric cancer in Taiwanese adults: referred to the Nationwide Reimbursement Database. Helicobacter. 2015;20:114–24.
36.
go back to reference Areia M, Carvalho R, Cadime AT, Rocha Goncalves F, Dinis-Ribeiro M. Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies. Helicobacter. 2013;18:325–37.CrossRefPubMed Areia M, Carvalho R, Cadime AT, Rocha Goncalves F, Dinis-Ribeiro M. Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies. Helicobacter. 2013;18:325–37.CrossRefPubMed
37.
go back to reference Lansdorp-Vogelaar I, Sharp L. Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention. Best Prac Res Clin Gastroenterol. 2013;27:933–47.CrossRef Lansdorp-Vogelaar I, Sharp L. Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention. Best Prac Res Clin Gastroenterol. 2013;27:933–47.CrossRef
38.
go back to reference Schulz TR, McBryde ES, Leder K, Biggs BA. Using stool antigen to screen for Helicobacter pylori in immigrants and refugees from high prevalence countries is relatively cost effective in reducing the burden of gastric cancer and peptic ulceration. PLoS One. 2014;9:e108610.CrossRefPubMedPubMedCentral Schulz TR, McBryde ES, Leder K, Biggs BA. Using stool antigen to screen for Helicobacter pylori in immigrants and refugees from high prevalence countries is relatively cost effective in reducing the burden of gastric cancer and peptic ulceration. PLoS One. 2014;9:e108610.CrossRefPubMedPubMedCentral
39.
go back to reference Marshall JK, Armstrong D, O’Brien BJ. Test-and-treat strategies for Helicobacter pylori in uninvestigated dyspepsia: a Canadian economic analysis. Can J Gastroenterol. 2000;14:379–88.CrossRefPubMed Marshall JK, Armstrong D, O’Brien BJ. Test-and-treat strategies for Helicobacter pylori in uninvestigated dyspepsia: a Canadian economic analysis. Can J Gastroenterol. 2000;14:379–88.CrossRefPubMed
40.
go back to reference Chiba N, Veldhuyzen Van Zanten SJ, Escobedo S, Grace E, Lee J, Sinclair P, et al. Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia. Aliment Pharmacol Ther. 2004;19:349–58.CrossRefPubMed Chiba N, Veldhuyzen Van Zanten SJ, Escobedo S, Grace E, Lee J, Sinclair P, et al. Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia. Aliment Pharmacol Ther. 2004;19:349–58.CrossRefPubMed
41.
go back to reference Masucci L, Blackhouse G, Goeree R. Cost-effectiveness of the carbon-13 urea breath test for the detection of Helicobacter pylori: an economic analysis. Ont Health Technol Assess Ser. 2013;13:1–28.PubMedPubMedCentral Masucci L, Blackhouse G, Goeree R. Cost-effectiveness of the carbon-13 urea breath test for the detection of Helicobacter pylori: an economic analysis. Ont Health Technol Assess Ser. 2013;13:1–28.PubMedPubMedCentral
42.
go back to reference Xie F, O’Reilly D, Ferrusi IL, Blackhouse G, Bowen JM, Tarride JE, et al. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada. J Am Coll Radiol. 2009;6:317–23.CrossRefPubMed Xie F, O’Reilly D, Ferrusi IL, Blackhouse G, Bowen JM, Tarride JE, et al. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada. J Am Coll Radiol. 2009;6:317–23.CrossRefPubMed
Metadata
Title
Higher risk of gastric cancer among immigrants to Ontario: a population-based matched cohort study with over 2 million individuals
Authors
Rinku Sutradhar
Nnenna Asidianya
Faith Lee
Natalie Coburn
Linda Rabeneck
Lawrence Paszat
Publication date
01-07-2018
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 4/2018
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-017-0790-x

Other articles of this Issue 4/2018

Gastric Cancer 4/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.